and therapeutic potential in several chronic inflammatory diseases, including cancer.
However, their physicochemical properties generally result in poor chemical stability and
lack of in vivo bioavailability. Very few human clinical trials have addressed absorption,
distribution, metabolism, and excretion of these compounds in relation to efficacy. This limits
the use of these valuable natural compounds in the clinic. In this study, we examined caffeic …